These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30186491)

  • 1. Luteolin decreases atherosclerosis in LDL receptor-deficient mice via a mechanism including decreasing AMPK-SIRT1 signaling in macrophages.
    Li J; Dong JZ; Ren YL; Zhu JJ; Cao JN; Zhang J; Pan LL
    Exp Ther Med; 2018 Sep; 16(3):2593-2599. PubMed ID: 30186491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-27 Prevents Atherosclerosis by Suppressing Lipoprotein Lipase-Induced Lipid Accumulation and Inflammatory Response in Apolipoprotein E Knockout Mice.
    Xie W; Li L; Zhang M; Cheng HP; Gong D; Lv YC; Yao F; He PP; Ouyang XP; Lan G; Liu D; Zhao ZW; Tan YL; Zheng XL; Yin WD; Tang CK
    PLoS One; 2016; 11(6):e0157085. PubMed ID: 27257686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteolin protects against vascular inflammation in mice and TNF-alpha-induced monocyte adhesion to endothelial cells via suppressing IΚBα/NF-κB signaling pathway.
    Jia Z; Nallasamy P; Liu D; Shah H; Li JZ; Chitrakar R; Si H; McCormick J; Zhu H; Zhen W; Li Y
    J Nutr Biochem; 2015 Mar; 26(3):293-302. PubMed ID: 25577468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
    Botham KM; Wheeler-Jones CP
    Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice.
    Liu TT; Zeng Y; Tang K; Chen X; Zhang W; Xu XL
    Atherosclerosis; 2017 Jul; 262():39-50. PubMed ID: 28500865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcuma oil attenuates accelerated atherosclerosis and macrophage foam-cell formation by modulating genes involved in plaque stability, lipid homeostasis and inflammation.
    Singh V; Rana M; Jain M; Singh N; Naqvi A; Malasoni R; Dwivedi AK; Dikshit M; Barthwal MK
    Br J Nutr; 2015 Jan; 113(1):100-13. PubMed ID: 25391643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of luteolin on transendothelial migration of monocytes and formation of lipid-laden macrophages.
    Kim MS; Kim DS; Kim HS; Kang SW; Kang YH
    Nutrition; 2012 Oct; 28(10):1044-54. PubMed ID: 22494633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOAT1 deficiency attenuates atherosclerosis by regulating inflammation and cholesterol transportation via HO-1 pathway.
    Wu N; Li RQ; Li L
    Biochem Biophys Res Commun; 2018 Jun; 501(2):343-350. PubMed ID: 29567472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral factors secreted from adipose tissue-derived mesenchymal stem cells ameliorate atherosclerosis in Ldlr-/- mice.
    Takafuji Y; Hori M; Mizuno T; Harada-Shiba M
    Cardiovasc Res; 2019 May; 115(6):1041-1051. PubMed ID: 30388208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disocin prevents postmenopausal atherosclerosis in ovariectomized LDLR-/- mice through a PGC-1α/ERα pathway leading to promotion of autophagy and inhibition of oxidative stress, inflammation and apoptosis.
    Yang Q; Wang C; Jin Y; Ma X; Xie T; Wang J; Liu K; Sun H
    Pharmacol Res; 2019 Oct; 148():104414. PubMed ID: 31449974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheb (Ras Homolog Enriched in Brain 1) Deficiency in Mature Macrophages Prevents Atherosclerosis by Repressing Macrophage Proliferation, Inflammation, and Lipid Uptake.
    Zhang Q; Hu J; Wu Y; Luo H; Meng W; Xiao B; Xiao X; Zhou Z; Liu F
    Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1787-1801. PubMed ID: 31315433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
    Stachon P; Peikert A; Michel NA; Hergeth S; Marchini T; Wolf D; Dufner B; Hoppe N; Ayata CK; Grimm M; Cicko S; Schulte L; Reinöhl J; von zur Muhlen C; Bode C; Idzko M; Zirlik A
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2237-45. PubMed ID: 25104800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expressions of atherosclerosis-related genes in aorta in young apoE/LDLR double knockout mice].
    Dai XD; Yin M; Jing W; DU HQ; Ye HY; Shang YJ; Zhang L; Zou YY; Qu ZP; Pan J
    Sheng Li Xue Bao; 2008 Feb; 60(1):43-50. PubMed ID: 18288357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE
    Xiong W; Wang X; Dai D; Zhang B; Lu L; Tao R
    Thromb Haemost; 2017 Jan; 117(2):401-414. PubMed ID: 27831589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice.
    Zhang WJ; Bird KE; McMillen TS; LeBoeuf RC; Hagen TM; Frei B
    Circulation; 2008 Jan; 117(3):421-8. PubMed ID: 18158360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.
    Hara T; Phuong PT; Fukuda D; Yamaguchi K; Murata C; Nishimoto S; Yagi S; Kusunose K; Yamada H; Soeki T; Wakatsuki T; Imoto I; Shimabukuro M; Sata M
    Circulation; 2018 Oct; 138(16):1706-1719. PubMed ID: 29700120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice.
    Park KY; Heo TH
    Cardiovasc Ther; 2018 Dec; 36(6):e12476. PubMed ID: 30378752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of resveratrol on foam cell formation are mediated through monocyte chemotactic protein-1 and lipid metabolism-related proteins.
    Dong W; Wang X; Bi S; Pan Z; Liu S; Yu H; Lu H; Lin X; Wang X; Ma T; Zhang W
    Int J Mol Med; 2014 May; 33(5):1161-8. PubMed ID: 24584901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages.
    Laguna-Fernandez A; Checa A; Carracedo M; Artiach G; Petri MH; Baumgartner R; Forteza MJ; Jiang X; Andonova T; Walker ME; Dalli J; Arnardottir H; Gisterå A; Thul S; Wheelock CE; Paulsson-Berne G; Ketelhuth DFJ; Hansson GK; Bäck M
    Circulation; 2018 Oct; 138(16):1693-1705. PubMed ID: 29739755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilirubin Prevents Atherosclerotic Lesion Formation in Low-Density Lipoprotein Receptor-Deficient Mice by Inhibiting Endothelial VCAM-1 and ICAM-1 Signaling.
    Vogel ME; Idelman G; Konaniah ES; Zucker SD
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28365565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.